MSB 2.98% $1.47 mesoblast limited

Ann: MSB Presents at Edison Group Global Healthcare Conference, page-258

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 35,472 Posts.
    lightbulb Created with Sketch. 2863
    https://hotcopper.com.au/threads/ann-msb-presents-at-edison-group-global-healthcare-conference.6546662/page-224?post_id=59216154

    debate it.
    you haven't got a clue have you?

    your own trial showed a better 28 OR (your primary) for Grade 4/D! (severe) at around 73%
    Grade B dragged the OR down. at 50%

    and their whole argument was "we treated more sick GVHD patients", however, it was children vs adults who don't respond as well
    and the comp achieved 100%/87% OR at 28 days.

    go on, debate it
    school me pleasebiggrin.png

    Last edited by Sector: 01/02/22
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.